| Dr Angela Fowler Stewart, OD | |
|
4807 Valley View Blvd Nw, Roanoke, VA 24012-2018 | |
| (540) 265-7420 | |
| Not Available |
| Full Name | Dr Angela Fowler Stewart |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 22 Years |
| Location | 4807 Valley View Blvd Nw, Roanoke, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124068606 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 0618001242 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dr Neal S Jessup Optometrist Pc | 1658303953 | 2 |
News Archive
The Hill examines Medicines for Malaria Venture's (MMV) efforts to get more U.S. funding for its work. According to the newspaper, the group is "asking USAID and Congress to redirect more money beginning next year to drug research and development from a pot of funds used to cover the range of efforts to treat and prevent malaria, such as providing mosquito nets."
Queen's University has announced it is to lead a -6 million European study to find new treatments for bowel cancer.
In the September 15th issue of Genes & Development, Drs. Richard T. Williams, Willem den Besten, and Charles J. Sherr at Howard Hughes Medical Institute, St. Jude Children's Research Hospital in Memphis TN, lend new insights into how an aggressive form of acute lymphoblastic leukemia (ALL) develops, and how sensitivity to the targeted chemotherapeutic drug, imatinib, can be diminished through interactions between tumor cells and the host microenvironment.
Your spit may hold a clue to future brain health. Investigators at the Beaumont Research Institute, part of Beaumont Health in Michigan, are hopeful that their study involving small molecules in saliva will help identify those at risk of developing Alzheimer's disease - a neurologic condition predicted to reach epidemic proportions worldwide by 2050.
› Verified 6 days ago
| Provider Name | Dr Neal S Jessup Optometrist Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1437206125 PECOS PAC ID: 1658303953 Enrollment ID: O20050907001238 |
News Archive
The Hill examines Medicines for Malaria Venture's (MMV) efforts to get more U.S. funding for its work. According to the newspaper, the group is "asking USAID and Congress to redirect more money beginning next year to drug research and development from a pot of funds used to cover the range of efforts to treat and prevent malaria, such as providing mosquito nets."
Queen's University has announced it is to lead a -6 million European study to find new treatments for bowel cancer.
In the September 15th issue of Genes & Development, Drs. Richard T. Williams, Willem den Besten, and Charles J. Sherr at Howard Hughes Medical Institute, St. Jude Children's Research Hospital in Memphis TN, lend new insights into how an aggressive form of acute lymphoblastic leukemia (ALL) develops, and how sensitivity to the targeted chemotherapeutic drug, imatinib, can be diminished through interactions between tumor cells and the host microenvironment.
Your spit may hold a clue to future brain health. Investigators at the Beaumont Research Institute, part of Beaumont Health in Michigan, are hopeful that their study involving small molecules in saliva will help identify those at risk of developing Alzheimer's disease - a neurologic condition predicted to reach epidemic proportions worldwide by 2050.
› Verified 6 days ago
| Provider Name | Dovie Eye Care Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1710136965 PECOS PAC ID: 6507922903 Enrollment ID: O20090310000620 |
News Archive
The Hill examines Medicines for Malaria Venture's (MMV) efforts to get more U.S. funding for its work. According to the newspaper, the group is "asking USAID and Congress to redirect more money beginning next year to drug research and development from a pot of funds used to cover the range of efforts to treat and prevent malaria, such as providing mosquito nets."
Queen's University has announced it is to lead a -6 million European study to find new treatments for bowel cancer.
In the September 15th issue of Genes & Development, Drs. Richard T. Williams, Willem den Besten, and Charles J. Sherr at Howard Hughes Medical Institute, St. Jude Children's Research Hospital in Memphis TN, lend new insights into how an aggressive form of acute lymphoblastic leukemia (ALL) develops, and how sensitivity to the targeted chemotherapeutic drug, imatinib, can be diminished through interactions between tumor cells and the host microenvironment.
Your spit may hold a clue to future brain health. Investigators at the Beaumont Research Institute, part of Beaumont Health in Michigan, are hopeful that their study involving small molecules in saliva will help identify those at risk of developing Alzheimer's disease - a neurologic condition predicted to reach epidemic proportions worldwide by 2050.
› Verified 6 days ago
| Provider Name | Kartesz Family Eye Care Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1073869202 PECOS PAC ID: 5991955213 Enrollment ID: O20121023000501 |
News Archive
The Hill examines Medicines for Malaria Venture's (MMV) efforts to get more U.S. funding for its work. According to the newspaper, the group is "asking USAID and Congress to redirect more money beginning next year to drug research and development from a pot of funds used to cover the range of efforts to treat and prevent malaria, such as providing mosquito nets."
Queen's University has announced it is to lead a -6 million European study to find new treatments for bowel cancer.
In the September 15th issue of Genes & Development, Drs. Richard T. Williams, Willem den Besten, and Charles J. Sherr at Howard Hughes Medical Institute, St. Jude Children's Research Hospital in Memphis TN, lend new insights into how an aggressive form of acute lymphoblastic leukemia (ALL) develops, and how sensitivity to the targeted chemotherapeutic drug, imatinib, can be diminished through interactions between tumor cells and the host microenvironment.
Your spit may hold a clue to future brain health. Investigators at the Beaumont Research Institute, part of Beaumont Health in Michigan, are hopeful that their study involving small molecules in saliva will help identify those at risk of developing Alzheimer's disease - a neurologic condition predicted to reach epidemic proportions worldwide by 2050.
› Verified 6 days ago
| Provider Name | Kartesz Eye Associates Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1447702303 PECOS PAC ID: 9638456155 Enrollment ID: O20170510000136 |
News Archive
The Hill examines Medicines for Malaria Venture's (MMV) efforts to get more U.S. funding for its work. According to the newspaper, the group is "asking USAID and Congress to redirect more money beginning next year to drug research and development from a pot of funds used to cover the range of efforts to treat and prevent malaria, such as providing mosquito nets."
Queen's University has announced it is to lead a -6 million European study to find new treatments for bowel cancer.
In the September 15th issue of Genes & Development, Drs. Richard T. Williams, Willem den Besten, and Charles J. Sherr at Howard Hughes Medical Institute, St. Jude Children's Research Hospital in Memphis TN, lend new insights into how an aggressive form of acute lymphoblastic leukemia (ALL) develops, and how sensitivity to the targeted chemotherapeutic drug, imatinib, can be diminished through interactions between tumor cells and the host microenvironment.
Your spit may hold a clue to future brain health. Investigators at the Beaumont Research Institute, part of Beaumont Health in Michigan, are hopeful that their study involving small molecules in saliva will help identify those at risk of developing Alzheimer's disease - a neurologic condition predicted to reach epidemic proportions worldwide by 2050.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Angela Fowler Stewart, OD 1430 Crutchfield St, Roanoke, VA 24019-4419 Ph: (540) 400-7977 | Dr Angela Fowler Stewart, OD 4807 Valley View Blvd Nw, Roanoke, VA 24012-2018 Ph: (540) 265-7420 |
News Archive
The Hill examines Medicines for Malaria Venture's (MMV) efforts to get more U.S. funding for its work. According to the newspaper, the group is "asking USAID and Congress to redirect more money beginning next year to drug research and development from a pot of funds used to cover the range of efforts to treat and prevent malaria, such as providing mosquito nets."
Queen's University has announced it is to lead a -6 million European study to find new treatments for bowel cancer.
In the September 15th issue of Genes & Development, Drs. Richard T. Williams, Willem den Besten, and Charles J. Sherr at Howard Hughes Medical Institute, St. Jude Children's Research Hospital in Memphis TN, lend new insights into how an aggressive form of acute lymphoblastic leukemia (ALL) develops, and how sensitivity to the targeted chemotherapeutic drug, imatinib, can be diminished through interactions between tumor cells and the host microenvironment.
Your spit may hold a clue to future brain health. Investigators at the Beaumont Research Institute, part of Beaumont Health in Michigan, are hopeful that their study involving small molecules in saliva will help identify those at risk of developing Alzheimer's disease - a neurologic condition predicted to reach epidemic proportions worldwide by 2050.
› Verified 6 days ago
Dr. Patrick Bruce Curran, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5049 Valley View Blvd Nw Ste A, Roanoke, VA 24012 Phone: 540-362-7565 Fax: 540-563-0441 | |
Dr. Timothy Raymond Poling, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4822 Valley View Blvd Nw Ste C, Roanoke, VA 24012 Phone: 540-563-8279 | |
Donald Mac Scothorn, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 70 Summerfield Ct, Roanoke, VA 24019 Phone: 540-966-6616 | |
Dr. Thomas Kent Wilcox, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4135 Franklin Rd, Roanoke, VA 24018 Phone: 540-776-2930 | |
National Optomectric Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4135 Franklin Road, Sw, Roanoke, VA 24018 Phone: 540-776-2930 Fax: 540-776-2932 | |
National Optometric Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4135 Franklin Rd, Roanoke, VA 24018 Phone: 540-776-2933 Fax: 540-776-2932 | |
Dr. Tracy Scheibe, Optometrist, P.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4524 Challenger Ave, Roanoke, VA 24012 Phone: 540-977-6022 Fax: 540-977-6023 |